LIGAND PHARMACEUTICALS (LGND) Forecast, Price Target & Analyst Ratings

NASDAQ:LGND • US53220K5048

Current stock price

231.82 USD
+8.58 (+3.84%)
At close:
231.733 USD
-0.09 (-0.04%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LIGAND PHARMACEUTICALS (LGND).

Forecast Snapshot

Consensus Price Target

Price Target
$250.00
+ 7.84% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$2.09
Revenue Estimate
60.153M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$250.00
Upside
+ 7.84%
From current price of $231.82 to mean target of $250.00, Based on 15 analyst forecasts
Low
$222.20
Median
$246.33
High
$290.85

Price Target Revisions

1 Month
0.68%
3 Months
0.68%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for LGND. The average price target is 250 USD. This implies a price increase of 7.84% is expected in the next year compared to the current price of 231.82.
The average price target has been revised upward by 0.68% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LGND Current Analyst RatingLGND Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

LGND Historical Analyst RatingsLGND Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
86.67%
LGND was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about LGND.
In the previous month the buy percentage consensus was at a similar level.
LGND was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-15CitigroupMaintains Buy -> Buy
2026-04-14HC Wainwright & Co.Maintains Buy -> Buy
2026-03-24CitigroupMaintains Buy -> Buy
2026-03-11B of A SecuritiesInitiate Buy
2026-02-27OppenheimerMaintains Outperform -> Outperform
2026-02-24HC Wainwright & Co.Maintains Buy -> Buy
2025-12-10RBC CapitalMaintains Outperform -> Outperform
2025-12-10StifelMaintains Buy -> Buy
2025-12-09CitigroupInitiate Buy
2025-11-10RBC CapitalMaintains Outperform -> Outperform
2025-11-07BenchmarkMaintains Buy -> Buy
2025-11-06HC Wainwright & Co.Maintains Buy -> Buy
2025-11-03OppenheimerMaintains Outperform -> Outperform
2025-09-03OppenheimerMaintains Outperform -> Outperform
2025-09-02BenchmarkMaintains Buy -> Buy
2025-08-28HC Wainwright & Co.Maintains Buy -> Buy
2025-08-08RBC CapitalMaintains Outperform -> Outperform
2025-07-30OppenheimerMaintains Outperform -> Outperform
2025-05-09OppenheimerMaintains Outperform -> Outperform
2025-04-10StifelInitiate Buy
2024-12-23BenchmarkReiterate Buy -> Buy
2024-12-16BarclaysMaintains Overweight -> Overweight
2024-12-11RBC CapitalMaintains Outperform -> Outperform
2024-12-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-12RBC CapitalMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$2.09
Revenue Estimate
60.153M
Revenue Q2Q
32.69%
EPS Q2Q
57.45%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
0.20%
Revenue (3 Months)
-1.93%
EPS (1 Month)
15.01%
EPS (3 Months)
9.14%

Next Earnings Summary

LGND is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 2.09 USD and the consensus revenue estimate is 60.15M USD.
The next earnings revenue estimate has been revised downward by 1.93% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
LGND revenue by date.LGND revenue by date.
131.314M
-33.07%		167.133M
27.28%		268.087M
60.40%		271.43M
1.25%		324.12M
19.41%		364.26M
12.38%		408.08M
12.03%		466.71M
14.37%		551.53M
18.17%		638.02M
15.68%		702.35M
10.08%
EBITDA
YoY % growth
LGND ebitda by date.LGND ebitda by date.
46.342M
-14.97%		58.26M
25.72%		80.974M
38.99%		156.79M
93.63%		212.48M
35.52%		204.61M
-3.70%		261.91M
28.00%		331.59M
26.60%		413.24M
24.62%		480.87M
16.37%		N/A
EBIT
YoY % growth
LGND ebit by date.LGND ebit by date.
9.821M
227.37%		23.021M
134.41%		47.199M
105.03%		121.74M
157.93%		168.52M
38.43%		190.81M
13.23%		187.32M
-1.83%		254M
35.60%		318.41M
25.36%		380.74M
19.58%		361.71M
-5.00%
Operating Margin
LGND operating margin by date.LGND operating margin by date.
7.48%13.77%17.61%44.85%51.99%52.38%45.90%54.42%57.73%59.68%51.50%
EPS
YoY % growth
LGND eps by date.LGND eps by date.
6.10
42.52%		5.71
-6.39%		8.04
40.81%		9.59
19.24%		11.89
23.99%		15.46
30.09%		11.48
-25.79%		14.80
28.98%		17.15
15.85%		18.97
10.65%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		2.09
57.45%		2.17
35.43%		2.49
-19.36%		2.43
20.53%
Revenue
Q2Q % growth		60.153M
32.69%		64.842M
36.15%		71.985M
-17.16%		74.938M
25.60%
EBITDA
Q2Q % growth		32.507M
216.56%		36.744M
36.03%		43.722M
-45.11%		43.639M
-18.91%
EBIT
Q2Q % growth		21.554M
158.80%		27.037M
178.16%		33.615M
-37.86%		38.999M
94.61%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LGND Yearly Revenue VS EstimatesLGND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
LGND Yearly EPS VS EstimatesLGND Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.36%
EPS Next 5 Year
12.98%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
13.85%
Revenue Next 5 Year
13.58%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
59.73%
EBIT Next 5 Year
45.87%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LIGAND PHARMACEUTICALS / LGND Forecast FAQ

What is the average price target for LIGAND PHARMACEUTICALS (LGND) stock?

15 analysts have analysed LGND and the average price target is 250 USD. This implies a price increase of 7.84% is expected in the next year compared to the current price of 231.82.

What is the next earnings date for LGND stock?

LIGAND PHARMACEUTICALS (LGND) will report earnings on 2026-05-06.

Can you provide the consensus estimates for LIGAND PHARMACEUTICALS next earnings?

The consensus EPS estimate for the next earnings of LIGAND PHARMACEUTICALS (LGND) is 2.09 USD and the consensus revenue estimate is 60.15M USD.

Can you provide the expected long term growth rate for LIGAND PHARMACEUTICALS stock?

The expected long term growth rate for LIGAND PHARMACEUTICALS (LGND) is 13.85%.